Sweden’s Arcam AB, has announced that it has received an order for five Arcam Q10 systems from Beijing AK Medical based in China. The systems will be used for volume production of orthopaedic implants.
Beijing AK Medical, established in 2003, specialises in the research, development, manufacture and sale of artificial joint prosthesis and surgical instruments. The company has been a customer of Arcam since 2010 and announced in August that they received formal approval from the Chinese State Food and Drug Administration (CFDA) for EBM manufactured implants.
This was the first CFDA marketing approval for an additively manufactured orthopaedic implant. “We are excited to move into volume production with the EBM technology. Having worked with Arcam since 2010 we are now ramping up our activities, following the recent approval by the CFDA”, stated Mr Li Zhi Jiang, CEO of Beijing AK Medical.
“We are happy to present this order from Beijing AK Medical, a customer since long and a leading Chinese Implant manufacturer, driving the adaptation to Additive Manufacturing in China. This order also shows that the implant industry in China is now moving to volume production of medical implants with our EBM technology,” stated Magnus René, CEO of Arcam.
To submit news and articles for publication on Metal Additive Manufacturing email us at [email protected]